Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in

Rio Grande Neurosciences Acquires Cervel Multi-Coil TMS Technology For Depression Treatment

On October 20, 2015, Rio Grande Neurosciences (RGN) announced it had acquired Cervel Neurotech’s multi-coil repetitive transcranial magnetic stimulation (rTMS) technology for treatment of drug-resistant depression. The acquisition included all related patent applications, issued patents, trademarks, and equipment. RGN added the Cervel rTMS technology to its core suite of non-invasive brain stimulation (NIBS) electroceuticals to treat central nervous system conditions, with a focus on brain trauma and neurodegenerative and psychiatric diseases. Financial details about the acquisition have not been disclosed.

The RGN NIBS technologies also includes targeted pulse electro magnetic field therapy (tPEMF) and closed-loop . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.